H Jane Hollingsworth

Affiliations

  • Director at Cervomed Inc. (CRVO), 2025-06-25
  • Chief Executive Officer at Nupathe Inc. (PATH), 2012-03-27
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
DFFN $0.61 32,786 $19,999.46 32,786 2021-05-13 Filing
PATH $2.56 20,000 $51,286.00 213,600 2011-09-09 Filing